Home

Current Issue

Archives

Guidelines for Authors

Classified Ads

Links

Search PubMed

Subscriptions

Subscriber Registration

Guidelines for Website Users

JRheum Update Service

Contact Info

VOLUME 32: SUPPLEMENT 76 SEPTEMBER 2005

Glucocorticoid/Inflammation Induced Osteoporosis
— Pleiotropic Effects of D-Hormone Analogs
Rio de Janeiro, Brazil
May 17, 2004

Introduction D-Hormones Alfacalcidol and Calcitriol for Prevention and Treatment of Glucocorticoid/Inflammation-Induced Osteoporosis

P.N. Sambrook, E. Schacht ......... 1

The D-Hormone Analog Alfacalcidol: The Pioneer Beyond the Horizon of Osteoporosis Treatment

H. Orimo, E. Schacht ......... 4

D-Hormone and the Immune System

M.T. Cantorna, B.D. Mahon ......... 11

Importance of Alfacalcidol in Clinical Conditions Characterized by High Rate of Bone Loss

J-Y. Reginster, M-P. Lecart, F. Richy ......... 21

Alfacalcidol Versus Plain Vitamin D in Inflammation-Induced Bone Loss

S.H. Scharla, E. Schacht, U.G. Lempert ......... 26

Alfacalcidol Versus Plain Vitamin D in the Treatment of Glucocorticoid/Inflammation-Induced Osteoporosis

J.D. Ringe, H. Faber, P. Fahramand, E. Schacht ......... 33

D-Hormones for Prevention of Bone Loss After Organ Transplant

P.N. Sambrook ......... 41

Low Creatinine Clearance, Glucocorticoid Treatment, Rheumatoid Arthritis — Different Etiologies for Low D-Hormone Syndrome and Its Associated Increased Risk for Falls

L.C. Dukas, E. Schacht ......... 44

Guest Editors:
ERICH SCHACHT, PhD
Department of Rheumatology and Rehabilitation
University Clinic Balgrist
Zurich, Switzerland

PHILIP N. SAMBROOK, MD
Professor of Rheumatology
Royal North Shore Hospital
St. Leonards
Sydney, New South Wales, Australia.

Supported by an unrestricted educational grant from
TEVA Pharmaceutical Industries Ltd. and TEIJIN Pharma Ltd.